Safety Incidents OSHA Severe Injury Reports · 2015–2025
5,189,992Inspections Most recent open 2026-07-18 Last loaded 2026-07-22

OSHA Inspection: SMITHKLINE BECHAM PHARMACEUTICALS CO

Planned inspection · Safety discipline

On , OSHA opened a planned safety inspection of SMITHKLINE BECHAM PHARMACEUTICALS CO in CARR 172 BO CERTENEJAS, CIDRA, PR 00739 (NAICS 000000). OSHA activity number 126917871.

What this inspection record means

OSHA opens inspections for many reasons — routine scheduling under a national or local emphasis program, an employee complaint or referral, or a follow-up after a reported injury. Opening or conducting an inspection is not itself an allegation or a finding that this employer broke any rule; any findings appear as the citations listed below, and citations can be contested, reduced, or withdrawn.

Watch Smithkline Becham Pharmaceuticals CO — free Get an email when a new federal OSHA severe-injury report for Smithkline Becham Pharmaceuticals CO is published. One employer, no account, unsubscribe in one click.
Site address
CARR 172 BO CERTENEJAS
City
CIDRA
State
PR
ZIP
00739
Mailing
PO BOX 11975, CIDRA, PR 00739
Inspection type
Planned (H)
Scope
Complete (A)
Discipline
Safety
Advance notice
No
Union status
N
Opened
Closing conference
Case closed
Last modified
Data loaded
NAICS code
000000
SIC code (legacy)
2834
Employees
700
Ownership type
A
Industry flags
Manufacturing safety.

No citations on file for this inspection — so there is no finding of any violation on this record. An inspection can be open and still ongoing, or closed with no violations at all; OSHA's citation feed is also backfilled in rolling windows, so citation rows for a very recent inspection may not have been ingested yet.

This record is reproduced from the U.S. Department of Labor Open Data API (OSHA inspection dataset). The original IMIS detail view is available at OSHA's Establishment Search for activity number 126917871.

Look up any company's OSHA accident reports by company, or browse severe injury reports by year, state, and company.